Photodynamic therapy for AMD and non-AMD patients: one-year results in Thais.

dc.contributor.authorRatanasukon, Mansingen_US
dc.contributor.authorVisaetsilpanonta, Siriraksaen_US
dc.contributor.authorHanutsaha, Pruten_US
dc.contributor.authorPatikulsila, Direken_US
dc.date.accessioned2009-05-27T19:27:24Z
dc.date.available2009-05-27T19:27:24Z
dc.date.issued2007-10-29en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.description.abstractOBJECTIVE: To evaluate the effect of photodynamic therapy (PDT) with verteporfin for age-related macular degeneration (AMD) and non-AMD in Thais, and compare with the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) study. MATERIAL AND METHOD: The authors prospectively evaluated all data of 51 eyes of 51 patients who had undergone PDT and accomplished a 1-year follow up. The assessments were divided into two categories: group 1 included three subsets of AMD, and group 2 was non-AMD. The first group classified into three subgroups: group 1A: AMD with subfoveal choroidal neovascularization (CNV) and TAP/VIP compatible with recommendation guidelines characteristics, group 1B: AMD with subfoveal CNV and TAP/VIP incompatible, and group 1C: AMD with non-subfoveal CNV. The measurement outcomes comprised of the baseline characteristics, change in visual acuity, and number of treatments. RESULTS: Thirty-eight eyes had CNV-related AMD and 13 eyes were non-AMD. At the 12-month examination, the mean visual acuity change in group 1A, 1B, 1C had increased 0.19 (p = 0.077), 0.14 (p = 0.076), and 0.24 (p = 0.003), respectively. The number of treatments was 1.8 in group 1A, 2.3 in group 1B, and 1.5 in group 1C. CONCLUSION: PDT is beneficial to Thai patients with AMD at first year even if they were not compatible with TAP/VIP criteria.en_US
dc.description.affiliationDepartment of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. mratanasukon@yahoo.comen_US
dc.identifier.citationRatanasukon M, Visaetsilpanonta S, Hanutsaha P, Patikulsila D. Photodynamic therapy for AMD and non-AMD patients: one-year results in Thais. Journal of the Medical Association of Thailand. 2007 Oct; 90(10): 2090-6en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/41162
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshChoroidal Neovascularizationen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMacular Degeneration --drug therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPhotochemotherapyen_US
dc.subject.meshPorphyrins --administration & dosageen_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshThailanden_US
dc.subject.meshTime Factorsen_US
dc.subject.meshTreatment Outcomeen_US
dc.subject.meshVisual Acuityen_US
dc.titlePhotodynamic therapy for AMD and non-AMD patients: one-year results in Thais.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: